Picture EBD Group BIO-Europe 2026 Köln Cologne to 23 Oct 650x100px

Financing › Details

908 Devices–SEVERAL: investment, 202111 public offering $100.8m net $94.4m with 3.15m shares common stock at $32/share

	Period	2021-11-15
	Predecessor	908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m net $136.6m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market
	Money taker	908 Devices Inc. (Nasdaq: MASS)
	Group	908 Devices (Group)
	Money source	SEVERAL
	Product	mass spectrometer
	Product 2	investment banking

Record changed: 2024-12-20

Picture Berlin Partner HealthCapital LSR Personalized Medicine 650x200px

More documents for 908 Devices (Group)

[1] 908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA....
[2] 908 Devices, Inc.. (3/7/22). "Press Release: 908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook". Boston, MA....
[3] 908 Devices, Inc.. (3/2/22). "Press Release: 908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to Its Board of Directors"....
[4] 908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA....
[5] 908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA....
[6] 908 Devices, Inc.. (12/18/20). "Press Release: 908 Devices Announces Pricing of Initial Public Offering"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com